The Anifrolumab PRIM Program

NCT06795893 · clinicaltrials.gov ↗

RECRUITING

Status

240

Enrollment

INDUSTRY

Sponsor class

Conditions

Systemic Lupus Erythematosus

Interventions

DRUG: Anifrolumab

Sponsor

AstraZeneca

Collaborators

[object Object]